These data are in line with the results of a systematic review [35] and a later study [36] which reported IgM aCL, anti-β2GPI, and anti-prothrombin antibodies to be less often associated with clinical events of APS than IgG. The gene discussed is F2; the disease is autoimmune polyendocrinopathy.